Dr Anna Nowak

Honorary Associate
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone +61 8 9346 3841
Fax +61 8 9346 3390

Map

Selected grants

2016

  • DREAM - A phase II trial of durvalumab with first line chemotherapy in mesothelioma with a safety run in; Nowak A; AstraZeneca Australia Pty Ltd/Research Support.

2015

  • Phase III trial of Concurrent & Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma; Nowak A, Rosenthal M, Simes R, Ryan G, Drummond K; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2004

  • The Zest Trial : a double-blind, placebo-controlled trial of Zolofts effects on symptoms and survival time in advanced cancer; Stockler M, Byrne M, Nowak A, Wilken N, Turner J, Wyld D; Cancer Council New South Wales/Research Project Grants.
  • The Zest Trial : a double-blind, placebo-controlled trial of Zolofts effects on symptoms and survival time in advanced cancer; Stockler M, Byrne M, Nowak A, Wilken N, Turner J, Wyld D; Cancer Council SA/Research Support.

2003

  • Validating the Pt DATA form as a pragmatic measure of health-related quality of life for oncology practice and research; Nowak A; Medical Oncology Group of Australia Inc/Research Grant.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • van den Bent, M., Baumert, B., Erridge, S., Vogelbaum, M., Nowak, A., Sanson, M., Brandes, A., Clement, P., Baurain, J., Mason, W., Wheeler, H., et al (2017). Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. The Lancet, 390(10103), 1645-1653. [More Information]
  • Nowak, A., Cebon, J., Hargreaves, C., Dhillon, H., Findlay, M., Gebski, V., Stockler, M. (2008). Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology, 4, 55-67. [More Information]
  • Ferguson, T., Wilcken, N., Vagg, R., Ghersi, D., Nowak, A. (2007). Taxanes for adjuvant treatment of early breast cancer. Cochrane Database of Systematic Reviews, Art. No.: CD004421(4), 1-50. [More Information]
  • Cebon, J., Hargreaves, C., Stockler, M., Boyer, M., Nowak, A., Dhillon, H., Gebski, V., Dickman, B., Findlay, M., Poon, A., et al (2006). Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. British Journal of Cancer, 95(7), 853-861. [More Information]
  • Stockler, M., Heritier, S., Nowak, A., Goldstein, D., Turner, J., Jefford, M., Glasgow, A., Abdi, E., Beale, P., Carter, C. (2006). The time taken to complete quality of life questionnaires in an advanced cancer trial. Journal of Clinical Oncology, 24(18S), 491s-491s.
  • Nowak, A., Stockler, M., Chow, P., Findlay, M. (2005). Use of Tamoxifen in Advanced-Stage Hepatocellular Carcinoma. Cancer, 103(7), 1408-1414. [More Information]
  • Nowak, A., Stockler, M., Byrne, M. (2004). Assessing Quality Of Life During Chemotherapy For Pleural Mesothelioma: Feasibility, Validity, And Results Of Using The European Organization For Research And Treatment Of Cancer Core Quality Of Life Questionnaire And Lung Cancer Module. Journal of Clinical Oncology, 22(15), 3172-3180. [More Information]
  • Nowak, A., Wilcken, N., Stockler, M., Hamilton, A., Ghersi, D. (2004). Systematic Review Of Taxane-Containing Versus Non-Taxane-Containing Regimens For Adjuvant And Neoadjuvant Treatment Of Early Breast Cancer. The Lancet Oncology, 5(6), 372-380. [More Information]
  • Nowak, A., Chow, P., Findlay, M. (2004). Systemic Therapy For Advanced Hepatocellular Carcinoma: A Review. European Journal of Cancer, 40(10), 1474-1484. [More Information]

2017

  • van den Bent, M., Baumert, B., Erridge, S., Vogelbaum, M., Nowak, A., Sanson, M., Brandes, A., Clement, P., Baurain, J., Mason, W., Wheeler, H., et al (2017). Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. The Lancet, 390(10103), 1645-1653. [More Information]

2008

  • Nowak, A., Cebon, J., Hargreaves, C., Dhillon, H., Findlay, M., Gebski, V., Stockler, M. (2008). Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology, 4, 55-67. [More Information]

2007

  • Ferguson, T., Wilcken, N., Vagg, R., Ghersi, D., Nowak, A. (2007). Taxanes for adjuvant treatment of early breast cancer. Cochrane Database of Systematic Reviews, Art. No.: CD004421(4), 1-50. [More Information]

2006

  • Cebon, J., Hargreaves, C., Stockler, M., Boyer, M., Nowak, A., Dhillon, H., Gebski, V., Dickman, B., Findlay, M., Poon, A., et al (2006). Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. British Journal of Cancer, 95(7), 853-861. [More Information]
  • Stockler, M., Heritier, S., Nowak, A., Goldstein, D., Turner, J., Jefford, M., Glasgow, A., Abdi, E., Beale, P., Carter, C. (2006). The time taken to complete quality of life questionnaires in an advanced cancer trial. Journal of Clinical Oncology, 24(18S), 491s-491s.

2005

  • Nowak, A., Stockler, M., Chow, P., Findlay, M. (2005). Use of Tamoxifen in Advanced-Stage Hepatocellular Carcinoma. Cancer, 103(7), 1408-1414. [More Information]

2004

  • Nowak, A., Stockler, M., Byrne, M. (2004). Assessing Quality Of Life During Chemotherapy For Pleural Mesothelioma: Feasibility, Validity, And Results Of Using The European Organization For Research And Treatment Of Cancer Core Quality Of Life Questionnaire And Lung Cancer Module. Journal of Clinical Oncology, 22(15), 3172-3180. [More Information]
  • Nowak, A., Wilcken, N., Stockler, M., Hamilton, A., Ghersi, D. (2004). Systematic Review Of Taxane-Containing Versus Non-Taxane-Containing Regimens For Adjuvant And Neoadjuvant Treatment Of Early Breast Cancer. The Lancet Oncology, 5(6), 372-380. [More Information]
  • Nowak, A., Chow, P., Findlay, M. (2004). Systemic Therapy For Advanced Hepatocellular Carcinoma: A Review. European Journal of Cancer, 40(10), 1474-1484. [More Information]

To update your profile click here. For support on your academic profile contact .